Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancer. [electronic resource]
Producer: 20050526Description: 720-9 p. digitalISSN:- 1084-9785
- Adult
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Breast Neoplasms -- diagnostic imaging
- Carcinoma, Ductal, Breast -- diagnostic imaging
- Female
- Glycoproteins -- immunology
- Humans
- Hyaluronan Receptors -- immunology
- Middle Aged
- Prospective Studies
- Radioimmunodetection
- Radioisotopes
- Rhenium
- Safety
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.